Export

Cytarabine
Essential medicine status
Section:
8. Immunomodulators and antineoplastics 8.2. Antineoplastics and supportive medicines 8.2.1. Cytotoxic medicines
ATC codes: L01BC01
EMLc
Indication
Burkitt lymphoma including Burkitt leukaemia ICD11 code: 2B55.6
INN
Cytarabine
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > unspecified: 100 mg in vial powder for injection
EML status history
First added in 1979 (TRS 641)
Changed in 2011 (TRS 965)
Changed in 2015 (TRS 994)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
Cytarabine
DrugBank
Cytarabine
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for cytarabine on the complementary list of the EML and EMLc for use in treatment protocols for Burkitt lymphoma was specifically endorsed. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for Burkitt lymphoma is attached.